Immunology (34 companies · 19 conditions)

Conditions

Systemic Lupus Erythematosus 13 Rheumatoid Arthritis 9 Systemic Sclerosis 7 Rare Idiopathic Inflammatory Myopathies 6 Rare Chronic Urticaria 5 Sjögren's Syndrome 4 Ulcerative Colitis 4 Crohn's Disease 3 ANCA-Associated Vasculitis 2 Rare Dermatomyositis 2 Rare Psoriatic Arthritis 2 Axial Spondyloarthritis 1 Cow's Milk Allergy 1 Graft-versus-Host Disease 1 Rare Graves' Disease 1 Hereditary Angioedema 1 Rare IgG4-Related Disease 1 Rare Leukocyte Adhesion Deficiency-I 1 Rare Peanut Allergy 1

Companies

Ticker	Company	Therapeutic areas	In Immunology	Lead stage	Programs
AGMB	Agomab Therapeutics	ImmunologyRespiratory Rare	1	Phase 2	4
ALLO	Allogene Therapeutics	ImmunologyOncology Rare	3	Phase 2	12
ANAB	AnaptysBio	DermatologyGI/Hepatology+2 Rare	1	Approved	6
RCUS	Arcus Biosciences	DermatologyImmunology+1	1	Phase 3	6
ARTV	Artiva Biotherapeutics	DermatologyImmunology+2 Rare	6	Phase 2	16
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	1	Approved	12
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	4	Phase 1	8
RNAC	Cartesian Therapeutics	ImmunologyNeurology+1 Rare	1	Phase 3	4
CLDX	Celldex Therapeutics	DermatologyImmunology+1	3	Phase 3	7
IPSC	Century Therapeutics	ImmunologyMetabolic+1 Rare	6	Phase 1	11
CLYM	Climb Bio	HematologyImmunology+1 Rare	2	Phase 2	7
CGEM	Cullinan Therapeutics	HematologyImmunology+2 Rare	4	NDA Submitted	10
DBVT	DBV Technologies	GI/HepatologyImmunology Rare	2	NDA Submitted	3
ENTA	Enanta Pharmaceuticals	DermatologyImmunology+1	1	Phase 3	6
EVMN	Evommune	DermatologyImmunology+1	3	Phase 2	6
IMVT	Immunovant	ImmunologyNeurology Rare	4	Phase 2	6
INAB	IN8bio	ImmunologyOncology	1	Phase 2	6
IXHL	Incannex Healthcare	ImmunologyNeurology+1	1	Phase 2	3
NTLA	Intellia Therapeutics	CardiovascularImmunology Rare	1	NDA Submitted	5
JBIO	Jade Biosciences	ImmunologyRenal Rare	1	Phase 2	6
KYTX	Kyverna Therapeutics	ImmunologyNeurology+1 Rare	1	NDA Submitted	7
INKT	MiNK Therapeutics	ImmunologyOncology+1 Rare	1	Phase 2	7
NKTR	Nektar Therapeutics	DermatologyImmunology+2	1	Phase 2	11
NKTX	Nkarta	ImmunologyNeurology+1 Rare	4	Phase 1	7
NRIX	Nurix Therapeutics	ImmunologyNeurology+1	1	Phase 2	15
ORKA	Oruka Therapeutics	DermatologyImmunology Rare	1	Phase 2	6
QNRX	Quoin Pharmaceuticals	DermatologyImmunology Rare	1	Phase 2	8
RCKT	Rocket Pharmaceuticals	CardiovascularImmunology Rare	1	Approved	4
SYRE	Spyre Therapeutics	Immunology	12	Phase 2	12
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	1	Approved	26
VOR	Vor Biopharma	ImmunologyNeurology Rare	1	Phase 3	4
XNCR	Xencor	HematologyImmunology+4 Rare	7	Approved	30
ZBIO	Zenas BioPharma	DermatologyImmunology+1 Rare	2	NDA Submitted	11
ZURA	Zura Bio	DermatologyImmunology Rare	1	Phase 2	4